Cargando…
Evaluating the performance of drug-repurposing technologies
Drug-repurposing technologies are growing in number and maturing. However, comparisons to each other and to reality are hindered because of a lack of consensus with respect to performance evaluation. Such comparability is necessary to determine scientific merit and to ensure that only meaningful pre...
Autores principales: | Schuler, James, Falls, Zackary, Mangione, William, Hudson, Matthew L., Bruggemann, Liana, Samudrala, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014214/ https://www.ncbi.nlm.nih.gov/pubmed/34400352 http://dx.doi.org/10.1016/j.drudis.2021.08.002 |
Ejemplares similares
-
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020) -
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020) -
352 Computational methods for predicting drug combinations for targeting KRAS mutations relevant to non-small cell lung cancer
por: Bruggemann, Liana, et al.
Publicado: (2022) -
Exploration of interaction scoring criteria in the CANDO platform
por: Falls, Zackary, et al.
Publicado: (2019) -
A Deep-Learning Proteomic-Scale Approach for Drug Design
por: Overhoff, Brennan, et al.
Publicado: (2021)